Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
57.76 USD | +2.42% | +0.52% | +0.47% |
Mar. 01 | BACKGROUND/Capital Markets Day at Bayer: To split up or not? | DP |
Feb. 21 | Transcript : The Andersons, Inc., Q4 2023 Earnings Call, Feb 21, 2024 |
Financials (USD)
Sales 2024 * | 13.47B | Sales 2025 * | 13.73B | Capitalization | 1.91B |
---|---|---|---|---|---|
Net income 2024 * | 87M | Net income 2025 * | 110M | EV / Sales 2024 * | 0.14 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
22.2
x | P/E ratio 2025 * |
17.5
x | Employees | 2,259 |
Yield 2024 * |
1.35% | Yield 2025 * |
1.38% | Free-Float | 94.21% |
Latest transcript on The Andersons, Inc.
1 day | -0.49% | ||
1 week | -3.56% | ||
Current month | -1.69% | ||
1 month | +6.05% | ||
3 months | +8.42% | ||
6 months | +8.09% | ||
Current year | -1.98% |
Managers | Title | Age | Since |
---|---|---|---|
Patrick Bowe
CEO | Chief Executive Officer | 65 | 15-11-01 |
Brian Valentine
DFI | Director of Finance/CFO | 54 | 18-07-31 |
Michael Anderson
CHM | Chairman | 72 | 87-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert King
BRD | Director/Board Member | 68 | 05-07-28 |
Director/Board Member | 60 | 07-11-30 | |
Michael Anderson
CHM | Chairman | 72 | 87-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 45 M€ | -2.89% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 57.9 | +2.66% | 46 784 |
24-04-18 | 56.4 | -0.49% | 140,968 |
24-04-17 | 56.68 | -1.00% | 143,355 |
24-04-16 | 57.25 | -0.23% | 115,065 |
24-04-15 | 57.38 | -0.23% | 153,848 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.98% | 1.91B | |
-12.29% | 1.66B | |
-1.21% | 1.29B | |
-5.20% | 1.03B | |
-10.74% | 994M | |
-16.05% | 984M | |
+14.75% | 735M | |
-6.88% | 421M | |
-66.86% | 357M | |
+44.26% | 315M |
- Stock Market
- Equities
- ANDE Stock